{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:01:59Z","timestamp":1790499719018,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL119508"],"award-info":[{"award-number":["HL119508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN268201700005C"],"award-info":[{"award-number":["HHSN268201700005C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["A129688"],"award-info":[{"award-number":["A129688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R25EB023856\\u201304"],"award-info":[{"award-number":["1R25EB023856\\u201304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.addr.2020.07.011","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T17:36:45Z","timestamp":1595180205000},"page":"170-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy"],"prefix":"10.1016","volume":"159","author":[{"given":"Alexander S.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2020.07.011_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.addr.2020.07.011_bb0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution pharmacology: opportunities for therapeutic innovation in inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2020.07.011_bb0020","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000069943.41206.BD","article-title":"Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken","volume":"107","author":"Shah","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0025","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2020.07.011_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.07.011_bb0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0040","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.07.011_bb0045","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","article-title":"Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases","volume":"19","author":"Spite","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.addr.2020.07.011_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2020.07.011_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","volume":"58","author":"Chiang","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsptsci.9b00075","article-title":"New advances in targeting the resolution of inflammation: implications for specialized pro-resolving mediator GPCR drug discovery","volume":"3","author":"Park","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.addr.2020.07.011_bb0070","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.07.011_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.07.011_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1065","article-title":"Targeted nanoparticles containing the proresolving peptide Ac2\u201326 protect against advanced atherosclerosis in hypercholesterolemic mice","volume":"7","author":"Fredman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0085","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Novel lipid mediators and resolution mechanisms in acute inflammation","volume":"177","author":"Serhan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2020.07.011_bb0090","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2\u2013nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2020.07.011_bb0100","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3389\/fimmu.2017.01400","article-title":"Pro-resolving mediators in regulating and conferring macrophage function","volume":"8","author":"Dalli","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2020.07.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94463","article-title":"Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli\u2013driven acute inflammation","volume":"3","author":"Motwani","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.addr.2020.07.011_bb0110","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","article-title":"Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B 4 synthesis by inhibiting a calcium-activated kinase pathway","volume":"111","author":"Fredman","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2020.07.011_bb0115","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1096\/fj.12-225615","article-title":"D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury","volume":"27","author":"Miyahara","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0120","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.88.4.1788","article-title":"Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury","volume":"88","author":"Tanaka","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvs135","article-title":"The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles","volume":"95","author":"Lacolley","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.addr.2020.07.011_bb0135","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17 R Epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2020.07.011_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.CIR.86.1.56","article-title":"Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy","volume":"86","author":"Brezinski","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0145","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1096\/fj.201700082R","article-title":"Biosynthesis of proresolving lipid mediators by vascular cells and tissues","volume":"31","author":"Chatterjee","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood-2013-04-496661","article-title":"A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation","volume":"122","author":"Brancaleone","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.addr.2020.07.011_bb0155","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.115.020633","article-title":"Formyl-peptide receptor 2\/3\/Lipoxin a 4 receptor regulates neutrophil-platelet aggregation and attenuates cerebral inflammation: impact for therapy in cardiovascular disease","volume":"133","author":"Vital","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0160","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3892\/mmr.2017.6195","article-title":"Signal transduction involved in lipoxin A4-induced protection of tubular epithelial cells against hypoxia\/reoxygenation injury","volume":"15","author":"Wu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2020.07.011_bb0165","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0170","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","article-title":"Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections","volume":"21","author":"Dalli","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113480","article-title":"The pro-resolving lipid mediator Maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells","volume":"9","author":"Chatterjee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2020.07.011_bb0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.116.307308","article-title":"Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology","volume":"119","author":"Sansbury","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0185","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1182\/blood.V94.12.4132","article-title":"Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions","volume":"94","author":"Filep","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.addr.2020.07.011_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2018.01.034","article-title":"Resolvin D1 blocks H 2 O 2 -mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions","volume":"117","author":"Chattopadhyay","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0195","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/cvr\/cvu224","article-title":"The role of the FPR2\/ALX receptor in atherosclerosis development and plaque stability","volume":"105","author":"Petri","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0205","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/ATVBAHA.112.249508","article-title":"Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions","volume":"32","author":"Norling","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2020.07.011_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2016.01.030","article-title":"Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury","volume":"65","author":"Wu","year":"2017","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.addr.2020.07.011_bb0215","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2014.11.010","article-title":"Aspirin-triggered 15-epi-lipoxin A4 signals through FPR2\/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation","volume":"179","author":"Petri","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174936","article-title":"Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate\/protein kinase A (cAMP\/PKA) pathway","volume":"12","author":"Mottola","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2020.07.011_bb0225","doi-asserted-by":"crossref","first-page":"L776","DOI":"10.1152\/ajplung.00177.2015","article-title":"Resolvin E 1 normalizes contractility, Ca 2+ sensitivity and smooth muscle cell migration rate in TNF-\u03b1- and IL-6-pretreated human pulmonary arteries","volume":"309","author":"Hiram","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0230","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/bph.14151","article-title":"Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619","volume":"175","author":"Jannaway","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2020.07.011_bb0235","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1096\/fj.14-265363","article-title":"Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice","volume":"29","author":"Akagi","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0240","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/j.jvs.2018.05.253","article-title":"Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model","volume":"68","author":"Spinosa","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.addr.2020.07.011_bb0245","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.addr.2020.07.011_bb0250","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/bph.14041","article-title":"Early treatment with resolvin E1 facilitates myocardial recovery from ischaemia in mice: early therapy with RvE1 improves cardiac recovery after MI","volume":"175","author":"Liu","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2020.07.011_bb0255","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.116.021894","article-title":"Resolvin D2 enhances postischemic revascularization while resolving inflammation","volume":"134","author":"Zhang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0260","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1096\/fj.201500155R","article-title":"Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling","volume":"30","author":"Elajami","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0265","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.117.032801","article-title":"ERV1\/ChemR23 signaling protects against atherosclerosis by modifying oxidized low-density lipoprotein uptake and phagocytosis in macrophages","volume":"138","author":"Laguna-Fernandez","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0270","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1096\/fj.201600144RR","article-title":"D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization","volume":"30","author":"Pope","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0275","first-page":"1025","article-title":"Resolvin D1 protects the liver from ischemia\/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis","volume":"1861","author":"Kang","year":"2016","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.addr.2020.07.011_bb0280","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/jth.13620","article-title":"Maresin 1 induces a novel pro-resolving phenotype in human platelets","volume":"15","author":"Lannan","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.addr.2020.07.011_bb0285","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood-2007-11-122598","article-title":"Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets","volume":"112","author":"Dona","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.addr.2020.07.011_bb0290","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/ATVBAHA.110.209908","article-title":"Resolvin E1 regulates adenosine diphosphate activation of human platelets","volume":"30","author":"Fredman","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2020.07.011_bb0295","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1073\/pnas.1407123111","article-title":"Maresin 1 biosynthesis during platelet\u2013neutrophil interactions is organ-protective","volume":"111","author":"Abdulnour","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2020.07.011_bb0300","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2020.07.011_bb0305","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/2047487317694464","article-title":"Low salivary resolvin D1 to leukotriene B 4 ratio predicts carotid intima media thickness: a novel biomarker of non-resolving vascular inflammation","volume":"24","author":"Thul","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2017.08.007","article-title":"Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease","volume":"125","author":"Bazan","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.addr.2020.07.011_bb0315","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.117.312472","article-title":"Impaired production and diurnal regulation of vascular RvD n-3 DPA increase systemic inflammation and cardiovascular disease","volume":"122","author":"Colas","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0320","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2020.07.011_bb0325","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/CIRCRESAHA.116.309492","article-title":"Resolving lipid mediators Maresin 1 and Resolvin D2 prevent atheroprogression in mice","volume":"119","author":"Viola","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0330","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1111\/bph.13707","article-title":"Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E\u2212\/\u2212 mice","volume":"174","author":"Petri","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2020.07.011_bb0335","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","article-title":"Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis","volume":"35","author":"Hasturk","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2020.07.011_bb0340","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cvr\/cvy316","article-title":"The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification","volume":"115","author":"Carracedo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0345","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/joim.12940","article-title":"Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease","volume":"286","author":"Carracedo","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2017.02.001","article-title":"Abdominal aortic aneurysm and omega-3 polyunsaturated fatty acids: mechanisms, animal models, and potential treatment","volume":"118","author":"Meital","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.addr.2020.07.011_bb0355","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10753-011-9294-8","article-title":"Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients","volume":"35","author":"Pillai","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.addr.2020.07.011_bb0360","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacbts.2018.08.005","article-title":"Resolution of inflammation through the Lipoxin and ALX\/FPR2 receptor pathway protects against abdominal aortic aneurysms","volume":"3","author":"Petri","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.addr.2020.07.011_bb0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1524-475X.2012.00853.x","article-title":"Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model: RvD2 prevents secondary necrosis in burns","volume":"21","author":"Bohr","year":"2013","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.addr.2020.07.011_bb0370","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan1471","article-title":"A cluster of immunoresolvents links coagulation to innate host defense in human blood","volume":"10","author":"Norris","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.addr.2020.07.011_bb0375","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9149(97)89334-4","article-title":"Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography","volume":"77","author":"Iliceto","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0380","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/j.1755-5922.2010.00190.x","article-title":"There is more to life than revascularization: therapeutic targeting of myocardial ischemia\/reperfusion injury: strategies to attenuate lethal reperfusion injury","volume":"29","author":"Bell","year":"2011","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.addr.2020.07.011_bb0385","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvt004","article-title":"Translating cardioprotection for patient benefit: position paper from the working group of cellular biology of the heart of the European Society of Cardiology","volume":"98","author":"Hausenloy","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0390","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10557-019-06884-y","article-title":"Resolvin D1 attenuates myocardial infarction in a rodent model with the participation of the HMGB1 pathway","volume":"33","author":"Liu","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.addr.2020.07.011_bb0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","article-title":"Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function","volume":"84","author":"Kain","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0400","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.3390\/md12115396","article-title":"Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression","volume":"12","author":"Gilbert","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.addr.2020.07.011_bb0405","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","article-title":"Resolvin E1 protects the rat heart against reperfusion injury","volume":"299","author":"Keyes","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13041-018-0351-1","article-title":"Resolvin D2 protects against cerebral ischemia\/reperfusion injury in rats","volume":"11","author":"Zuo","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.addr.2020.07.011_bb0415","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4103\/1673-5374.180750","article-title":"Anti-inflammatory properties of lipoxin A4 protect against diabetes mellitus complicated by focal cerebral ischemia\/reperfusion injury","volume":"11","author":"Han","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0420","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2016.02.090","article-title":"The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia\/reperfusion injury by attenuating the pro-inflammatory response","volume":"472","author":"Xian","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2020.07.011_bb0425","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1007\/s12035-018-0889-z","article-title":"Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX\/FPR2 receptor-regulated MicroRNAs","volume":"55","author":"Bisicchia","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0430","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","author":"Kooij","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.addr.2020.07.011_bb0435","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.intimp.2015.06.017","article-title":"Resolvin D1 protects against hepatic ischemia\/reperfusion injury in rats","volume":"28","author":"Zhang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2020.07.011_bb0440","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.intimp.2017.08.008","article-title":"Protective effect of aspirin-triggered resolvin D1 on hepatic ischemia\/reperfusion injury in rats: the role of miR-146b","volume":"51","author":"Zhang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2020.07.011_bb0445","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.bbrc.2019.05.041","article-title":"Resolvin D1 activates the sphingosine-1-phosphate signaling pathway in murine livers with ischemia\/reperfusion injury","volume":"514","author":"Kang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2020.07.011_bb0450","first-page":"1111","article-title":"Role and related mechanism of resolvin D1 in lung ischemia reperfusion injury in rats","volume":"99","author":"Xia","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.addr.2020.07.011_bb0455","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4049\/jimmunol.1400497","article-title":"Both PD-1 ligands protect the kidney from ischemia reperfusion injury","volume":"194","author":"Jaworska","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2020.07.011_bb0460","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury","volume":"177","author":"Duffield","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2020.07.011_bb0465","first-page":"1139","article-title":"Lipoxin A4 pretreatment mitigates skeletal muscle ischemia-reperfusion injury in rats","volume":"9","author":"Zong","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0470","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2019.10.008","article-title":"Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure","volume":"31","author":"Tourki","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.addr.2020.07.011_bb0475","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1253\/circj.CJ-10-0495","article-title":"Mechanisms of vein graft adaptation to the arterial circulation: – insights into the neointimal algorithm and management strategies &ndash","volume":"74","author":"Muto","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.addr.2020.07.011_bb0480","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","article-title":"In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia","volume":"31","author":"Kornowski","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0485","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcvm.2018.00003","article-title":"Inflammation in vein graft disease","volume":"5","author":"de Vries","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.addr.2020.07.011_bb0495","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/j.jvs.2010.01.077","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: a survival prediction model to facilitate clinical decision making","volume":"51","author":"Bradbury","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.addr.2020.07.011_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2014.00017","article-title":"The importance of patency in patients with critical limb ischemia undergoing endovascular revascularization for infrapopliteal arterial disease","volume":"1","author":"Baumann","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0505","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1096\/fj.201800173R","article-title":"Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration","volume":"32","author":"Liu","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2020.07.011_bb0510","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jss.2018.07.049","article-title":"Proresolving lipid mediators resolvin D1 and protectin D1 isomer attenuate neointimal hyperplasia in the rat carotid artery balloon injury model","volume":"233","author":"Makino","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0515","doi-asserted-by":"crossref","first-page":"106401","DOI":"10.1016\/j.prostaglandins.2019.106401","article-title":"Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model","volume":"146","author":"Mottola","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.addr.2020.07.011_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2018.05.206","article-title":"Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model","volume":"68","author":"Wu","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.addr.2020.07.011_bb0525","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.actbio.2019.07.037","article-title":"Regulation of the inflammatory response by vascular grafts modified with aspirin-triggered Resolvin D1 promotes blood vessel regeneration","volume":"97","author":"Shi","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2020.07.011_bb0530","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000482","article-title":"Omega-3 polyunsaturated fatty acid (Fish Oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American heart association","volume":"135","author":"Siscovick","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0535","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n\u20133 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"The ORIGIN Trial Investigators","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0540","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified Omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2020.07.011_bb0545","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2020.07.011_bb0550","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0555","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n\u22123 fatty acids and prevention of cardiovascular disease and Cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0560","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002034","article-title":"Short-term, high-dose fish oil supplementation Increases the production of omega-3 fatty acid\u2013derived mediators in patients with peripheral artery disease (the OMEGA-PAD I Trial)","volume":"4","author":"Grenon","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.addr.2020.07.011_bb0565","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish oil increases specialized pro-resolving lipid mediators in PAD (the OMEGA-PAD II trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2020.07.011_bb0570","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jacl.2017.06.011","article-title":"Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements","volume":"11","author":"Schaller","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.addr.2020.07.011_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016113","article-title":"Treatment with a marine oil supplement alters lipid mediators and leukocyte phenotype in healthy subjects and those with peripheral arterial disease","author":"Schaller","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.addr.2020.07.011_bb0580","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2020.07.011_bb0585","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2015.08.049","article-title":"COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance","volume":"785","author":"Poorani","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2020.07.011_bb0590","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0595","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.07.011_bb0600","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.plefa.2007.08.001","article-title":"The two faces of the 15-lipoxygenase in atherosclerosis","volume":"77","author":"Wittwer","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.addr.2020.07.011_bb0605","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.18632\/aging.101077","article-title":"Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction","volume":"8","author":"Halade","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.addr.2020.07.011_bb0610","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","article-title":"18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling","volume":"211","author":"Endo","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2020.07.011_bb0615","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","article-title":"Therapeutic potential of lipoxin a 4 in chronic inflammation: focus on cardiometabolic disease","volume":"3","author":"Fu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.addr.2020.07.011_bb0620","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpharm.2015.12.037","article-title":"Topical delivery of aqueous micellar resolvin E1 analog (RX-10045)","volume":"498","author":"Cholkar","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.07.011_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.10.023","article-title":"Identification of chemotype agonists for human resolvin D1 receptor DRV1 with pro-resolving functions","volume":"26","author":"Chiang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2020.07.011_bb0630","doi-asserted-by":"crossref","first-page":"L904","DOI":"10.1152\/ajplung.00370.2014","article-title":"Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent","volume":"308","author":"Orr","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.addr.2020.07.011_bb0635","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1172\/JCI97947","article-title":"Pro-resolving lipid mediators in vascular disease","volume":"128","author":"Conte","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.07.011_bb0640","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:20:34Z","timestamp":1777515634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X20300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":128,"alternative-id":["S0169409X20300958"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2020.07.011","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2020.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}